Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry

被引:8
|
作者
Ellefsen, Kayla N. [1 ,2 ]
Concheiro, Marta [1 ]
Suzuki, Masaki [3 ,4 ]
Rice, Kenner C. [3 ,4 ]
Elmore, Joshua S. [5 ]
Baumann, Michael H. [5 ]
Huestis, Marilyn A. [1 ]
机构
[1] NIDA, Chem & Drug Metab, Intramural Res Program, NIH, Baltimore, MD 21224 USA
[2] Univ Maryland, Toxicol Program, Baltimore, MD 21201 USA
[3] NIDA, Drug Design & Synth Sect, Intramural Res Program, Baltimore, MD 21224 USA
[4] NIAAA, NIH, Baltimore, MD USA
[5] NIDA, Designer Drug Res Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA
基金
美国国家卫生研究院;
关键词
Methylone; Synthetic cathinones; Novel designer drugs; Metabolites; 4-Hydroxy-3-methoxymethcathinone; LC-MS/MS; SYNTHETIC CATHINONES; DESIGNER DRUG; BATH SALTS; MEPHEDRONE; MDPV;
D O I
10.1007/s11419-015-0263-z
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Methylone is a commonly abused synthetic cathinone derivative marketed as a "legal" alternative to "ecstasy" or cocaine. Previous studies examined the metabolism of methylone in vitro and in vivo; 4-hydroxy-3-methoxymethcathinone (HMMC) was identified as the primary metabolite, with other reported minor metabolites, 3,4-methylenedioxycathinone (MDC) and 3,4-dihydroxymethcathinone (HHMC). However, limited information is known about methylone and its metabolites' pharmacokinetics. We developed and fully validated a method for the simultaneous quantification of methylone, HMMC, MDC and HHMC by liquid chromatography-tandem mass spectrometry in 100 A mu l rat and human plasma. beta-Glucuronidase was utilized for plasma hydrolysis, followed by perchloric acid protein precipitation and solid-phase extraction utilizing cation exchange columns. Chromatographic separation was performed with a Synergi Polar column in gradient mode, and analytes were determined by two multiple reaction monitoring (MRM) transitions. Linear ranges of 0.5-1,000 A mu g/l (methylone, HMMC and MDC) and 10-1,000 A mu g/l (HHMC) were achieved. Bias and imprecision were generally acceptable, although quantification of HHMC exhibited variability (16.2-37 %). Extraction efficiencies and ion suppression were 89.9-104 % (for HHMC, 15.9-16.2 %) and < 11.4 %, respectively. Methylone and metabolites were stable in plasma for 24 h at room temperature, 72 h at 4 A degrees C, and after three freeze-thaw cycles (except for a 60 % HMMC increase). Human and rat plasma were cross-validated, documenting that rat plasma quality control samples were accurately quantified against a human plasma calibration curve (-23.8 to 12 % bias). As proof of method, rat plasma specimens were analyzed pre-injection and after subcutaneous administration of methylone at 6 mg/kg from 15 to 480 min post-dosing. Methylone, HMMC, MDC and HHMC concentrations ranged from 1.1 to 1,310, 11.2 to 194, 1.9 to 152 and 24.7 to 188 A mu g/l, respectively.
引用
收藏
页码:202 / 212
页数:11
相关论文
共 50 条
  • [31] Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometry
    Balakirouchenane, David
    Khoudour, Nihel
    Guegan, Sarah
    Kramkimel, Nora
    Franck, Nathalie
    Rodier, Thomas
    Goldwasser, Francois
    Dupin, Nicolas
    Aractingi, Selim
    Vidal, Michel
    Blanchet, Benoit
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 193
  • [32] Quantification of cyclizine and norcyclizine in human plasma by liquid chromatography-tandem mass spectrometry (LC-MS/MS)
    Jensen, Berit Packert
    Vella-Brincat, Jane Winifred Ann
    Begg, Evan James
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (9-10): : 605 - 609
  • [33] Determination of nicousamide in human plasma by liquid chromatography-tandem mass spectrometry
    Qi, Wenyuan
    Zhao, Qian
    Liu, Hongzhong
    Jiang, Ji
    Chen, Xiaoguang
    Hu, Pei
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 77 : 158 - 162
  • [34] Analysis of cyclosporine A and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry
    Fang, Zhi-gang
    You, Ben-gang
    Chen, Ya-gen
    Zhang, Jian-kang
    Liu, Yue-qing
    Zhang, Xue-nong
    Zhang, Qiang
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (15-16): : 1153 - 1162
  • [35] Determination of silodosin in human plasma by liquid chromatography-tandem mass spectrometry
    Zhao, Xia
    Liu, Yuwang
    Xu, Junyu
    Zhang, Dan
    Zhou, Ying
    Gu, Jingkai
    Cui, Yimin
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (29): : 3724 - 3728
  • [36] Determination of voriconazole in human plasma by liquid chromatography-tandem mass spectrometry
    Teng, G-Sh.
    Zhao, L. -Z.
    Li, X.
    BULGARIAN CHEMICAL COMMUNICATIONS, 2016, 48 (01): : 147 - 152
  • [37] Determination of solifenacin in human plasma by liquid chromatography-tandem mass spectrometry
    Macek, Jan
    Ptacek, Pavel
    Klima, Josef
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (31): : 3327 - 3330
  • [38] Determination of celecoxib in human plasma by liquid chromatography-tandem mass spectrometry
    Ptacek, Pavel
    Klima, Josef
    Macek, Jan
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 899 : 163 - 166
  • [39] Determination of telmisartan in human plasma by liquid chromatography-tandem mass spectrometry
    Li, PF
    Wang, YW
    Wang, Y
    Tang, YB
    Fawcett, JP
    Cui, YM
    Gu, JK
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 828 (1-2): : 126 - 129
  • [40] Liquid chromatography-tandem mass/mass spectrometry method for the quantification of rabeprazole in human plasma and application to a pharmacokinetic study
    Yu, Liyan
    Deng, Haishan
    Xiang, Bingren
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2010, 60 (05): : 262 - 266